Solara Active Pharma Sciences Stock Screener | Share Price & Fundamental Analysis
SOLARA
Pharmaceuticals
Screen Solara Active Pharma Sciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹576.45
▼
-5.60 (-0.96%)
Share Price BSE
₹576.25
▼
-6.55 (-1.12%)
Market Cap
₹1,992.64 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.61
EPS (TTM)
₹0.14
Dividend Yield
-
Debt to Equity
0.89
52W High
₹702.55
52W Low
₹450.30
Operating Margin
17.00%
Profit Margin
-0.72%
Revenue (TTM)
₹279.00
EBITDA
₹51.00
Net Income
₹-2.00
Total Assets
₹2,232.00
Total Equity
₹1,097.00
Solara Active Pharma Sciences Share Price History - Stock Screener Chart
Screen SOLARA historical share price movements with interactive charts. Analyze price trends and patterns.
Solara Active Pharma Sciences Company Profile - Fundamental Screener
Screen Solara Active Pharma Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SOLARA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE624Z01016
Solara Active Pharma Sciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SOLARA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Assets | 729 | 801 | 1,188 | 1,239 | 1,058 | 672 | 648 | 608 |
| Fixed Assets | 1,193 | 1,268 | 1,364 | 1,356 | 1,382 | 1,397 | 1,218 | 1,086 |
| Liabilities | ||||||||
| Total Liabilities | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Liabilities | 191 | 172 | 296 | 354 | 232 | 333 | 344 | 315 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 1,097 | 937 | 1,502 | 1,527 | 1,593 | 1,090 | 960 | 769 |
| Share Capital | 40 | 36 | 36 | 36 | 36 | 27 | 26 | 25 |
| Reserves & Surplus | 1,054 | 898 | 1,464 | 1,489 | 1,553 | 963 | 826 | 739 |
Screen SOLARA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 279 | 320 | 314 | 301 | 364 | 347 | 302 | 385 | 354 | 426 | 212 | 367 | 337 | 342 | 402 |
| Expenses | 228 | 262 | 279 | 412 | 322 | 286 | 243 | 332 | 333 | 393 | 436 | 349 | 318 | 311 | 350 |
| EBITDA | 51 | 58 | 35 | -111 | 43 | 62 | 59 | 53 | 21 | 34 | -224 | 18 | 20 | 31 | 52 |
| Operating Profit % | 17.00% | 18.00% | 11.00% | -38.00% | 12.00% | 18.00% | 19.00% | 13.00% | 5.00% | 8.00% | -106.00% | 3.00% | 4.00% | 8.00% | 11.00% |
| Depreciation | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 27 | 26 | 26 | 26 | 28 | 28 | 29 | 28 |
| Interest | 29 | 24 | 21 | 31 | 31 | 28 | 27 | 22 | 25 | 24 | 25 | 22 | 23 | 22 | 24 |
| Profit Before Tax | -2 | 11 | -10 | -167 | -14 | 8 | 8 | 5 | -29 | -17 | -275 | -31 | -31 | -19 | 1 |
| Tax | 0 | 0 | 0 | 89 | 0 | 0 | 0 | 1 | -10 | 0 | 0 | -33 | -15 | -9 | 0 |
| Net Profit | -2 | 11 | -10 | -255 | -14 | 8 | 8 | 4 | -19 | -17 | -275 | 2 | -17 | -10 | 0 |
| EPS | -0.93 | 2.46 | -2.36 | -70.93 | -3.50 | 2.54 | 2.03 | 1.05 | -5.43 | -4.77 | -72.07 | 0.53 | -4.56 | -2.77 | 0.12 |
Solara Active Pharma Sciences Cash Flow Screener - Liquidity Fundamentals
Screen SOLARA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 213 | 109 | 156 | -242 | 156 | 242 | 166 | 49 |
| Investing Activities | -37 | -4 | -81 | -243 | -106 | -359 | -113 | -86 |
| Financing Activities | -181 | -106 | -113 | 334 | 93 | 97 | -23 | 68 |
| Net Cash Flow | -5 | 0 | -38 | -151 | 142 | -20 | 30 | 32 |
Screen SOLARA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 37.94% | 42.01% | 42.01% | 30.49% | 37.27% | 37.27% | 37.23% | 40.97% |
| FII Holding | 14.63% | 14.25% | 13.58% | 15.80% | 14.00% | 14.25% | 14.67% | 0.00% |
| DII Holding | 2.61% | 2.62% | 2.69% | 2.97% | 2.83% | 3.38% | 3.19% | 2.22% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.07% | 23.47% | 24.01% | 20.15% | 19.61% | 18.83% | 21.93% | 16.23% |
| Other Holding | 21.74% | 17.63% | 17.70% | 30.59% | 26.29% | 26.28% | 22.98% | 40.58% |
| Shareholder Count | 75,791 | 74,334 | 72,479 | 73,912 | 78,617 | 71,882 | 83,148 | 76,325 |
Solara Active Pharma Sciences Dividend Screener - Share Yield Analysis
Screen SOLARA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹3.00 | 0.88% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹7.00 | 1.14% |
| 2020-March | ₹2.00 | 0.16% |
| 2019-March | ₹5.00 | 1.22% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Solara Active Pharma Sciences Index Membership - Market Screener Classification
Screen SOLARA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Solara Active Pharma Sciences Market Events Screener - Corporate Actions
Screen SOLARA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 1.99% | ||
| Annual General Meeting | NA | 6.04% | ||
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | 4.97% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -5.15% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 19.48% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 4.29% |
| 2024-10-21 | 2024-10-21 | Quarterly Result Announcement | NA | 8.18% |
| 2024-05-15 | 2024-05-15 | Rights | 1:3 | 8.26% |
| 2021-08-18 | 2021-08-20 | Dividend | ₹ 3.00 /share | 5.36% |
| 2017-03-25 | 2017-03-25 | Change Of Name | NA | - |
Solara Active Pharma Sciences Competitors Screener - Peer Comparison
Screen SOLARA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Solara Active Pharma Sciences Company Announcements - News Screener
Screen SOLARA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-12-17 | Reconstitution Of The Management Committee | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-12-17 | Board Meeting Outcome for Board Meeting Outcome For Solara Active Pharma Sciences Limited Held On December 17 2025 | View |
| 2025-12-05 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-12-04 | Clarification On Volume Movement | View |
| 2025-12-04 | Clarification sought from Solara Active Pharma Sciences Ltd | - |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-05 | General-Updates | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-05 | Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended September 30 2025. | View |
| 2025-11-05 | Intimation Regarding The Grant Of ESOP | View |
| 2025-11-05 | Intimation About Appointment Of Mr. Mohanraj S As Chief Human Resources Officer (CHRO) | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |